Clinical and Molecular Hepatology10.3350/cmh.2023.00802023292332-334What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?Min Kyung Park, Yoon Jun Kim,,
Liver Transplantation10.1002/lt.20605200511S2S45-S46Tumor surveillance-what can and should be done? Screening for recurrence of hepatocellular carcinoma after liver transplantationJohn P. Roberts,
Clinical and Molecular Hepatology10.3350/cmh.2023.01012023292352-354Challenges in translating clinical guidelines into real-life practice for management of hepatocellular carcinoma in TaiwanSan-Chi Chen,,
Clinical and Molecular Hepatology10.3350/cmh.2023.01022023292242-251Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspectiveHironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi,,
EAU Update Series10.1016/j.euus.2004.01.0042004212-5Diagnosis and Assessment of BPH: What Should Be Done? A Glance at International Clinical Practice GuidelinesJacques Irani, Christian T Brown,
Best Practice & Research Clinical Haematology10.1016/j.beha.2023.1014732023362101473What should be done and what should be avoided when comparing two treatments?Florie Brion Bouvier, Raphaƫl Porcher,
Clinical and Molecular Hepatology10.3350/cmh.2023.00822023292349-351Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gapShen-Yung Wang,,
Liver Cancer10.1159/00036773020154285-95Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe,
Journal of Liver Cancer10.17998/jlc.2022.11.0720232311-1202022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma,,
The Korean Journal of Hepatology10.3350/kjhep.2009.15.3.3912009153391Practice guidelines for management of hepatocellular carcinoma 2009,, J Hepatol_15_3_391_448.pdf